Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-11-17

Clinical Trial Update: Development of a Molecular Diagnosing Platform for Relieving Periodontal Symptoms

View source ↗

Summary

The study reports completion of a trial evaluating a molecular diagnostic platform for periodontal diseases, including peri-implantitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: General Biologicals Corporation | Conditions: Periodontal Diseases, Peri-Implantitis | Status: COMPLETED